Company Recognition and Innovation - The company was selected as a national-level "specialized, refined, and innovative" small giant enterprise, enhancing its brand recognition and industry influence[4] - The company added 11 invention patents and 32 utility model and design patents during the reporting period, totaling 20 invention patents, 111 utility model patents, and 4 design patents to date[4] - The company holds a total of 135 authorized patents, including 20 invention patents, 111 utility model patents, and 4 design patents[39] - The company has been recognized as a national-level "specialized, refined, characteristic, and innovative" enterprise, enhancing its brand recognition and industry influence[40] - The company emphasizes independent innovation and has established a robust R&D team to enhance its competitive edge[198] Financial Performance - The company's operating revenue for 2023 was approximately ¥188.45 million, representing a year-over-year increase of 0.39% compared to ¥187.72 million in 2022[22] - The net profit attributable to shareholders for 2023 decreased by 43.29% to ¥16.33 million from ¥28.79 million in 2022[22] - The gross profit margin for 2023 was 31.16%, down from 33.96% in 2022[22] - The total assets as of the end of 2023 were approximately ¥490.51 million, a decrease of 0.70% from ¥493.99 million at the end of 2022[24] - The total liabilities increased by 5.94% to ¥232.07 million in 2023 from ¥219.07 million in 2022[24] - The company's basic earnings per share for 2023 was ¥0.16, a decrease of 42.86% from ¥0.28 in 2022[22] - The company reported a significant decline in net profit growth rate of -53.69% in 2023 compared to a growth of 36.29% in 2022[25] - The company achieved operating revenue of 188.45 million yuan, a year-on-year increase of 0.39%, and a total profit of 13.54 million yuan, a decrease of 57.07% compared to the previous year[38] Research and Development - R&D investment reached 20.22 million yuan, accounting for 132.32% of net profit and 10.73% of operating revenue, with a year-on-year increase of 13.21%[39] - The company expanded its R&D personnel from 38 to 47, increasing the proportion of R&D staff to 18.73%[87] - The company is focusing on talent development and retention to strengthen its core team and enhance competitive capabilities[43] - The company is increasing R&D investment to enhance product quality and innovation, particularly in new military oxygen masks and polyurethane materials[105] Market Expansion and Strategic Initiatives - The company continues to expand its market presence in both military and civilian sectors, focusing on innovative product development in polyurethane functional films and other new materials[33] - The company plans to invest in a new project for PCM nano-composite materials to support the production of next-generation functional composite films[41] - The company signed a procurement framework agreement with Shanghai Commercial Aviation and entered the qualified supplier directory of China Commercial Aircraft Corporation, enhancing its market position[43] - The company is actively expanding sales channels and developing new customers to reduce reliance on the top five customers[104] Operational Efficiency and Cost Management - The company plans to maintain high R&D investment to strengthen its core technology advantages and improve product quality, focusing on market-driven innovation[101] - Production efficiency will be improved through enhanced manufacturing processes and employee training, aiming to reduce costs and increase output[102] - The company has implemented measures to control costs and optimize supplier management to stabilize procurement prices and minimize impacts on current performance[106] Risks and Challenges - The company has identified significant risks in revenue recognition related to rubber products and functional films, necessitating thorough internal control evaluations[91] - The company is assessing expected credit losses for accounts receivable, which significantly impacts financial statements[92] - The company faces risks related to potential declines in gross profit margin due to rising labor and material costs, as well as pending military pricing approvals for several products[106] Corporate Governance and Shareholder Relations - The company has a clear profit distribution policy that allows minority shareholders to express their opinions and ensures their legal rights are protected[158] - The independent directors approved the annual profit distribution plan, which was subsequently ratified by the shareholders' meeting[157] - The company has committed to implementing stock price stabilization measures for three years from the date of stock issuance[130] - The company has no major related party transactions during the reporting period[115] Environmental and Social Responsibility - The company actively participates in rural revitalization projects, contributing to poverty alleviation and social responsibility initiatives[93] - The company emphasizes environmental protection and sustainable practices while ensuring compliance with safety regulations[95] Future Outlook - The company expects significant growth in its military products business due to increased defense spending and the need for weaponry upgrades, aligning with global geopolitical trends[96] - The company is positioned to benefit from the ongoing modernization of the military and defense sectors, which are expected to see substantial growth in both scale and technological advancement[184] - The company plans to continue expanding its market presence and product offerings in the coming year[80]

审计报告 XYZH/2024BJAG1B0229 南通通易航天科技股份有限公司 南通通易航天科技股份有限公司全体股东： 一、 审计意见 我们审计了南通通易航天科技股份有限公司（以下简称通易航天公司）财务报表， 包括 2023 年 12 月 31 日的合并及母公司资产负债表，2023 年度的合并及母公司利润表、 合并及母公司现金流量表、合并及母公司股东权益变动表，以及相关财务报表附注。 我们认为，后附的财务报表在所有重大方面按照企业会计准则的规定编制，公允反 映了通易航天公司 2023 年 12 月 31 日的合并及母公司财务状况以及 2023 年度的合并及 母公司经营成果和现金流量。 二、 形成审计意见的基础 我们按照中国注册会计师审计准则的规定执行了审计工作。审计报告的"注册会计 师对财务报表审计的责任"部分进一步阐述了我们在这些准则下的责任。按照中国注册 会计师职业道德守则，我们独立于通易航天公司，并履行了职业道德方面的其他责任。 我们相信，我们获取的审计证据是充分、适当的，为发表审计意见提供了基础。 三、 关键审计事项 关键审计事项是我们根据职业判断，认为对本期财务报表审计最为重要的事项。这 些事项的应 ...

证券代码：871642 证券简称：通易航天 公告编号：2024-013 南通通易航天科技股份有限公司 回购进展情况公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、误导 性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带法律责任。 一、 回购方案基本情况 (一)审议及表决情况 南通通易航天科技股份有限公司（以下简称"公司"）于 2023 年 11 月 13 日召开了 第五届董事会第十三次会议、第五届监事会第十二次会议，审议通过了《关于回购股份 方案的议案》。根据《公司章程》的有关规定，本议案无需提交股东大会审议。 (二)回购用途及目的 基于对公司未来发展的信心和对公司价值的认可，为进一步完善公司治理结构，构 建长期激励与约束机制，充分调动公司员工的积极性，确保公司长期经营目标的实现， 在综合考虑公司经营情况、财务状况及未来发展战略等因素的基础上，公司拟以自有资 金回购公司股份，并将用于实施股权激励或员工持股计划。 自董事会决议至回购完成期间，如公司存在权益分派等事项，将自权益分派实施之 日起，及时调整回购价格。 (五) 拟回购数量、资金总额及资金来源 本次拟回购资金总 ...

| 日期 | 代码 | 简称 | 成交价 | 成交数量（股） | 买入营业部 | 卖出营业部 | | --- | --- | --- | --- | --- | --- | --- | | 2024-03- | 830809 | 安达科技 | 3.5 | 200000 | 国泰君安证券股份有 | 中原证券股份有限公 | | 21 | | | | | 限公司北京亦庄宏达 | 司北京分公司 | | | | | | | 北路营业部 | | | 2024-03- | 870976 | 视声智能 | 12.88 | 265459 | 东方证券股份有限公 | 中信证券股份有限公 司杭州新城路证券营 | | 21 | | | | | 司上海虹口区曲阳路 | | | | | | | | 证券营业部 | 业部 | | 2024-03- | 830809 | 安达科技 | 3.4 | 200000 | 海通证券股份有限公 | 中泰证券股份有限公 司烟台正阳路证券营 | | 21 | | | | | 司烟台解放路营业部 | | | | | | | | | 业部 | | 2024-03- | 871642 | 通易航天 | | | ...

证券代码：871642 证券简称：通易航天 公告编号：2024-012 南通通易航天科技股份有限公司 持股 5%以上股东权益变动超过 1%的提示性公告 二、本次权益变动情况 | 股东名称 | 变动方式 | 减持股份（股） | 减持比例（%） | | --- | --- | --- | --- | | 黎又佳 | 大宗交易 | 1,550,000 | 1.5% | 三、本次变动前后，投资者及其一致行动人拥有上市公司权益的股份情况 | 股东名称 | 本次变动前持有股份 | | | 本次变动后持有股份 | | --- | --- | --- | --- | --- | | | 股数（股） | 占总股本比 | 股数（股） | 占总股本比 | | | | 例（%） | | 例（%） | | 黎又佳 | 5,418,000 | 5.23% | 3,868,000 | 3.73% | | 蒋炜 | 2,843,480 | 2.74% | 2,843,480 | 2.74% | | | | 注：上述股份均为无限售条件股份 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假 记载误导性陈述或者重大遗漏，并对其内容的 ...

| 日期 | 代码 | 简称 | 成交价 | 成交数量（股） | 买入营业部 | 卖出营业部 | | --- | --- | --- | --- | --- | --- | --- | | 2024-03- | | | | | 华泰证券股份有限公 | 国投证券股份有限公 | | 18 | 831167 | 鑫汇科 | 9.17 | 100000 | 司深圳深南大道证券 | 司深圳深南大道本元 | | | | | | | 营业部 | 大厦证券营业部 | | 2024-03- | | | | | 广发证券股份有限公 | 申万宏源证券有限公 | | 18 | 871642 | 通易航天 | 11.49 | 550000 | 司上海控江路营业部 | 司上海浦东新区东方 | | | | | | | | 路证券营业部 | ...

| 日期 | 代码 | 简称 | 成交价 | 成交数量（股） | 买入营业部 | 卖出营业部 | | --- | --- | --- | --- | --- | --- | --- | | 2024-03- | | | | | 海通证券股份有限公 | 海通证券股份有限公 | | 13 | 832471 | 美邦科技 | 8.83 | 100000 | 司山西转型综合改革 | 司山西转型综合改革 | | | | | | | 示范区分公司 | 示范区分公司 | | 2024-03- 13 | 871642 | 通易航天 | 10.85 | 330000 | 广发证券股份有限公 司上海控江路营业部 | 申万宏源证券有限公 司上海浦东新区东方 | | | | | | | | 路证券营业部 | | 2024-03- | | | | | 联储证券股份有限公 | 华泰证券股份有限公 | | 13 | 836414 | 欧普泰 | 12.1 | 255000 | 司上海中山西路证券 | 司上海武定路证券营 | | | | | | | 营业部 | 业部 | ...

| 日期 | 代码 | 简称 | 成交价 | 成交数量（股） | 买入营业部 | 卖出营业部 | | --- | --- | --- | --- | --- | --- | --- | | 2024-03- | | | | | 中国中金财富证券有 | 中山证券有限责任公 | | 12 | 839729 | 永顺生物 | 4.02 | 150000 | 限公司广州珠江新城 | 司广州花城大道证券 | | | | | | | 证券营业部 | 营业部 | | 2024-03- 12 | 871642 | 通易航天 | 10.85 | 500000 | 广发证券股份有限公 司上海控江路营业部 | 申万宏源证券有限公 司上海浦东新区东方 | | | | | | | | 路证券营业部 | ...

| 2024-03- | | | | | | | 申万宏源证券有限公 | | --- | --- | --- | --- | --- | --- | --- | --- | | 01 | 871642 | | 通易航天 | 10 | 170000 | 司上海万源路证券营 | 司上海浦东新区东方 | | 日期 | | 代码 | 简称 | 成交价 | 成交数量（股） | 买入营业部 中信证券股份有限公 业部 | 卖出营业部 路证券营业部 | ...

证券代码：871642 证券简称：通易航天 公告编号：2024-010 南通通易航天科技股份有限公司 回购进展情况公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、误导 性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带法律责任。 一、 回购方案基本情况 (一)审议及表决情况 南通通易航天科技股份有限公司（以下简称"公司"）于 2023 年 11 月 13 日召开了 第五届董事会第十三次会议、第五届监事会第十二次会议，审议通过了《关于回购股份 方案的议案》。根据《公司章程》的有关规定，本议案无需提交股东大会审议。 (二)回购用途及目的 基于对公司未来发展的信心和对公司价值的认可，为进一步完善公司治理结构，构 建长期激励与约束机制，充分调动公司员工的积极性，确保公司长期经营目标的实现， 在综合考虑公司经营情况、财务状况及未来发展战略等因素的基础上，公司拟以自有资 金回购公司股份，并将用于实施股权激励或员工持股计划。 (五) 拟回购数量、资金总额及资金来源 本次拟回购资金总额不少于 6,000,000.00 元，不超过 10,000,000.00 元，同时 根据拟回购资金 ...